Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases
Monday, January 13, 2025Gilead Sciences Inc and LEO Pharma today announced a strategic partnership to accelerate the development and commercialization of LEO Pharmas small molecule oral STAT signal transducer and activator of transcription programs for the potential treatm...
Bayer submits application to U.S. FDA and to China’s CDE for new indication of finerenone for patients with common form of heart failure with high unmet medical need
Monday, January 13, 2025Bayer today announced the submission of marketing authorization applications to the US Food and Drug Administration FDA and to the Center of Drug Evaluation CDE of Chinas National Medical Products Administration NMPA seeking approval of finerenone in...
Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment
Friday, January 10, 2025Abivax SA a clinicalstage biotechnology company developing innovative therapies to address chronic inflammatory diseases today announced a significant milestone in the Phase ABTECT clinical trial evaluating obefazimod for the treatment of moderately...
Bayer Acquires Camelina Assets from Smart Earth Camelina Corp. to Advance Biofuels
Friday, January 10, 2025Bayer today announced a deal with Canadabased Smart Earth Camelina Corp whereby Bayer has acquired their camelina germplasm intellectual property and materials to expand its global leadership position in biomassbased feedstock markets This acquisitio...
Zai Lab Announces National Medical Products Administration (NMPA) Approval of AUGTYRO™ (repotrectinib) for Patients with NTRK-Positive Solid Tumors
Thursday, January 09, 2025Zai Lab Limited today announced that Chinas National Medical Products Administration NMPA has approved the supplemental New Drug Application sNDA for AUGTYRO repotrectinib for the treatment of adult patients with solid
Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments
Thursday, January 09, 2025Johnson Johnson healthcares leading most comprehensive innovation powerhouse today announced a voluntary agreement with the Trump Administration to improve access to medicines and lower costs for millions of American patients
Merck’s GARDASIL® Receives Expanded Approval for Males in China
Thursday, January 09, 2025Merck known as MSD outside of the United States and Canada today announced that the National Medical Products Administration NMPA of China approved GARDASIL Human Papillomavirus Quadrivalent Types and Vaccine Recombinant for use in males years
DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study
Thursday, January 09, 2025DBV Technologies a clinicalstage biopharmaceutical company today announced positive twentyfour month results from its OpenLabel Extension OLE Study of EPITOPE Phase trial of VIASKIN peanut g VP in toddlers ages to years The data provide support
Transforming Pharma Manufacturing: The Pharma Smart Manufacturing 2025 Conference
Thursday, January 09, 2025In a world where technology and human ingenuity converge the pharmaceutical industry stands on the brink of revolutionary change To explore these transformative opportunities Fleming is proud to present the Pharma Smart Manufacturing Conference
Quris-AI's Bio-AI Platform Integrated by Merck KGaA, Darmstadt, Germany for Preclinical Small Molecule Drug Safety Evaluation
Wednesday, January 08, 2025QurisAI an artificial intelligence AI innovator disrupting the pharmaceutical arena today announced that Merck KGaA Darmstadt Germany a leading science and technology company has adopted Quris BioAI clinical prediction platform as part of Merck KGaA
